Medlac Pharma

Hanoi, Vietnam Founded: 2008 • Age: 18 yrs Acquired By Hikma
Developer and manufacturer of pharmaceutical parental products
Request Access

About Medlac Pharma

Medlac Pharma is a company based in Hanoi (Vietnam) founded in 2008 was acquired by Hikma in November 2018.. Medlac Pharma offers products and services including Vial Production and Ampoule Production. Medlac Pharma operates in a competitive market with competitors including Exela Pharma, Gland Pharma, August Bioservices, ApiJect and Vetter Pharma, among others.

  • Headquarter Hanoi, Vietnam
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Medlac Pharma Italy Co.,Ltd
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Hikma

    (Nov 07, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Medlac Pharma

Medlac Pharma offers a comprehensive portfolio of products and services, including Vial Production and Ampoule Production. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Produces vials for pharmaceutical drug storage and delivery.

Manufactures ampoules for sterile liquid medications.

Funding Insights of Medlac Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Medlac Pharma

Medlac Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Hikma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Generics and pharmaceutical products are manufactured by Hikma.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Medlac Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Medlac Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Medlac Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Medlac Pharma

Medlac Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, Gland Pharma, August Bioservices, ApiJect and Vetter Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
domain founded_year HQ Location
Generic injectable drugs are manufactured across therapeutic segments.
domain founded_year HQ Location
Diversified research services for clinical solutions are offered.
domain founded_year HQ Location
Medicine injectors are manufactured by ApiJect for medical applications.
domain founded_year HQ Location
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
domain founded_year HQ Location
Injectable drug products are manufactured by this biopharma CDMO.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Medlac Pharma

Korean drugmaker buys large Vietnamese plant
Fiercepharma6 years ago
Hikma Pharmaceuticals to acquire Medlac Pharma
Seekingalpha7 years ago

Frequently Asked Questions about Medlac Pharma

When was Medlac Pharma founded?

Medlac Pharma was founded in 2008.

Where is Medlac Pharma located?

Medlac Pharma is headquartered in Hanoi, Vietnam.

Who is the current CEO of Medlac Pharma?

Alfonso Sciotti is the current CEO of Medlac Pharma.

What does Medlac Pharma do?

Medlac Pharma was founded in 2008 and is based in Hanoi, Vietnam. Operations focus on the pharmaceutical sector, where parenteral products are developed and manufactured. Therapeutic categories covered include analgesics such as NSAIDs, cardiovascular agents, antibiotics, antidotes, corticosteroids, anesthetics, nootropics, muscle relaxants, multivitamins, and additional areas. The company serves these needs through standard production processes in the region.

Who are the top competitors of Medlac Pharma?

Medlac Pharma's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.

What products or services does Medlac Pharma offer?

Medlac Pharma offers Vial Production and Ampoule Production.

Who are Medlac Pharma's investors?

Medlac Pharma has 1 investor. Key investors include Hikma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available